# Use of GnRHa During Chemotherapy for Fertility Protection

> **NCT05328258** · PHASE3 · RECRUITING · sponsor: **Kenny Rodriguez-Wallberg** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer Female
- Acute Leukemia
- Lymphoma
- Osteosarcoma
- Soft Tissue Sarcoma
- Ewing Sarcoma

## Interventions

- **DRUG:** Triptorelin Embonate
- **DRUG:** Sodium Chloride solution 0.9%

## Key facts

- **NCT ID:** NCT05328258
- **Lead sponsor:** Kenny Rodriguez-Wallberg
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-31
- **Primary completion:** 2028-01-01
- **Final completion:** 2032-01-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05328258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05328258, "Use of GnRHa During Chemotherapy for Fertility Protection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05328258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*